Inovatyvios medicinos iniciatyva – IMI2

Konsultuoja teminės srities atstovė, NCP: dr. Edita Bagdonaitė, Šis el. pašto adresas yra apsaugotas nuo šiukšlių. Jums reikia įgalinti JavaScript, kad peržiūrėti jį.

Work programme: H2020-JTI-IMI-2019

Kvietimo identifikatorius ir pavadinimasFinansavimo schemos kodasKvietimo paskelbimo dataParaiškos priimamos iki
(pirmojo/antrojo etapo paraiškų priėmimo data, jei taikoma dviejų pakopų schema)
IMI2-2019-17-01: Optimising future obesity treatment IMI2-RIA 2019-01-22 (2019-04-25/2019-11-07)
IMI2-2019-17-02: Open access chemogenomics library and chemical probes for the druggable genome IMI2-RIA 2019-01-22 (2019-04-25/2019-11-07)
IMI2-2019-17-03: Intelligent prediction and identification of environmental risks posed by human medicinal products IMI2-RIA 2019-01-22 (2019-04-25/2019-11-07)
IMI2-2019-18-01: Central repository of digital pathology slides to support the development of artificial intelligence tools IMI2-RIA 2019-06-26 (2019-09-26/2020-03-26)
IMI2-2019-18-02: Health Outcomes Observatories – empower patients with tools to measure their outcomes in a standardised manner creating transparency of health outcomes IMI2-RIA 2019-06-26 (2019-09-26/2020-03-26)
IMI2-2019-18-03: Improving patient access, understanding and adherence to healthcare information: an integrated digital health information project IMI2-RIA 2019-06-26 (2019-09-26/2020-03-26)
IMI2-2019-18-04: Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials IMI2-RIA 2019-06-26 (2019-09-26/2020-03-26)
IMI2-2019-18-05: Accelerating research & innovation for advanced therapy medicinal products IMI2-RIA 2019-06-26 (2019-09-26/2020-03-26)
IMI2-2019-18-06: Supporting the development of engineered T cells IMI2-RIA 2019-06-26 (2019-09-26/2020-03-26)